Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darvadstrocel in pediatric Crohn's disease with complex perianal fistula
NCT04701411Phase 3Terminated
- Sponsor
- Takeda
- Start
- Jun 2021
- Primary completion
- May 2025
- Modality
- Stem Cell Therapies
- Countries
- 5
01
Overview
A Phase 3 trial of darvadstrocel in perianal fistula, sponsored by Takeda. Started Jun 2021; status: terminated.
02
Drugs
darvadstrocel
03
Conditions
perianal fistula
Beyond the preview
Go deeper on NCT04701411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04701411.